GSTM1 and adenoma: Using the lowest positivity threshold of 2.5 μg Hb/g feces, FIT identified 4/4 CRCs, 4/5 advanced adenomas, 1/4 advanced serrated lesions, and 9/57 non-advanced adenomas, resulting in a 26% sensitivity and 72% NPV (Table 2, Figure 2).